Perlecan, the multidomain HS-proteoglycan of basement membranes, is a prominent pericellular component of ovine hypertrophic vertebral growth plate and cartilaginous endplate chondrocytes

Histochemistry and Cell Biology

Volumn 118, Issue 4, 2002, Pages 269-280

  Melrose, James ^a   Smith, Susan ^a   Knox, Sarah ^c   Whitelock, John ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CSIRO   (Australia)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cartilaginous endplate; Intervertebral disc; Perlecan; Vertebral growth plate

Indexed keywords

AGGRECAN; CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGEN TYPE 6; CORE PROTEIN; EPITOPE; HYALURONIC ACID; KERATAN SULFATE; MONOCLONAL ANTIBODY; PERLECAN; HERMES ANTIGEN; PROTEOHEPARAN SULFATE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CARTILAGE MATRIX; CELL DIFFERENTIATION; CONTROLLED STUDY; GROWTH PLATE; IMMUNOLOCALIZATION; NONHUMAN; PRIORITY JOURNAL; SHEEP; ANIMAL; BASEMENT MEMBRANE; CYTOLOGY; ENZYME IMMUNOASSAY; EXTRACELLULAR MATRIX; HYPERTROPHY; INTERVERTEBRAL DISK; LUMBAR VERTEBRA; METABOLISM; NEWBORN;

ANIMALIA; OVIS; OVIS ARIES;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; BASEMENT MEMBRANE; CHONDROCYTES; EXTRACELLULAR MATRIX; GROWTH PLATE; HEPARAN SULFATE PROTEOGLYCANS; HYALURONIC ACID; HYPERTROPHY; IMMUNOENZYME TECHNIQUES; INTERVERTEBRAL DISK; LUMBAR VERTEBRAE; SHEEP;

EID: 0036399319     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00418-002-0449-4     Document Type: Article

References (72)

1. Aigner T, Greskötter KR, Fiarbank JCT, Von der Mark K, Urban JPG (1998) Variation with age in the pattern of type X collagen expression in normal and scoliotic human intervertebral discs. Calcif Tissue Int 63:263-268
2. Arikawa-Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada Y (1999) Perlecan is essential for cartilage and cephalic development. Nat Genet 23:354-358
3. Arikawa-Hirasawa E, Wilcox WR, Le AH, Silverman N, Govindraj P, Hassell JR, Yamada Y (2001a) Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutation of the perlecan gene. Nat Genet 27:431-434
4. Arikawa-Hirasawa E, Wilcox WR, Yamada Y (2001b) Dyssegmental dysplasia, Silverman-Handmaker type: unexpected role of perlecan in cartilage development. Am J Med Genet (Semin Med Genet) 106:254-257
5. Arikawa-Hirasawa E, Le AH, Nishino I, Nonaka I, Ho NC, Francomano CA, Govindraj P, Hassell JR, Devaney JM, Spranger J, Stevenson RE, Iannaccone S, Dalakas M (2002) Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome with myotonic myopathy and chondroplasia. Am J Hum Genet 70:1368-1375
6. Aszodi A, Bateman JF, Gustafsson E, Boot-Handford R, Fässler R (2000) Mammalian skeletogenesis and extracellular matrix: what can we learn from knockout mice. Cell Struct Funct 25:73-84
7. Aviezer D (1994) Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis and angiogenesis. Cell 79:1005-1013
8. Boos N, Nerlich AG, Wiest I, Von der Mark K, Aebi M (1997) Immunolocalisation of type X collagen in human lumbar intervertebral disc during ageing and degeneration. Histochem Cell Biol 108:471-480
9. Burgeson RE, Hollister DW (1979) Collagen heterogeneity in human cartilage: identification of several new collagen chains. Biochem Biophys Res Commun 87:1124-1131
10. Byers S, Van Rooden JC, Foster BK (1997) Structural changes in the large proteoglycan aggrecan in different zones of the ovine growth plate. Calcif Tissue Int 60:71-78
11. Carlson CS, Loeser RF, Johnstone B, Tulli HM, Dobson DB, Caterson B (1995) Osteoarthritis in cynomolgus macaques. II. Detection of modulated proteoglycan epitopes in cartilage and synovial fluid. J Orthop Res 13:399-409
12. Carson DD, Tang J-P, Julian J (1993) Heparan sulphate proteoglycan (perlecan) expression by mouse embryos during acquisition of attachment competence. Dev Biol 155:97-106
13. Caterson B, Christner JE, Baker JR (1983) Identification of a monoclonal antibody that specifically recognizes corneal and skeletal keratan sulfate. Monoclonal antibodies to cartilage proteoglycan. J Biol Chem 258:8848-8854
14. Caterson B, Christner JE, Baker JR, Couchman JR (1985) Production and characterisation of monoclonal antibodies against connective tissue proteoglycans. Fed Proc Fed Am Soc Exp Biol 44:386-393
15. Caterson B, Calabro T, Hampton A (1987) Monoclonal antibodies as probes for elucidating proteoglycan structure and function. In: Wright T, Mecham R (eds) Biology of proteoglycans. Academic Press, New York, pp 1-26
16. Caterson B, Mahmoodian F, Sorrell JM, Hardingham TE, Bayliss MT, Carney SL, Ratcliffe A, Muir H (1990a) Modulation of native chondroitin sulphate structure in tissue development and in disease. J Cell Sci 97:411-417
17. Caterson B, Calabro T, Hardingham TE (1990b) Markers of osteoarthritis: immunological aspects. In: Brandt KE (ed) Cartilage changes in osteoarthritis. Indiana University School of Medicine Publications, Indianapolis, pp 89-97
18. Chang Z, Meyer K, Repraeger AC, Friedl A (2000) Differential ability of HS proteoglycans to assemble the fibroblast growth factor receptor complex in situ. FASEB J 14:137-144
19. Chen Q, Fitch JM, Linsenmeyer C, Linsenmeyer TF (1992) Type X collagen: covalent crosslinking to hypertrophic cartilage collagen fibrils Bone Miner 17:223-227
20. Clayton A, Thomas J, Thomas GJ, Davies M, Steadman R (2001) Cell surface HS proteoglycans control the response of renal interstitial fibroblasts to FGF-2. Kidney Int 59:2084-2094
21. Costell M, Gustafsson E, Aszodi A. Morgelin M, Bloch W, Hunziker E, et al (1999) Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 147:1109-1122
22. French MM, Smith SE, Akanbi K, Sanford T, Hecht J, Farach-Carson MC, Carson DD (1999) Expression of HS proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. J Cell Biol 145:1103-1115
23. French MM, Gomes RR, Timpl R, Hook M, Czymmek K, Farach-Carson MC, Carson DD (2002) Chondrogenic activity of the heparan sulphate proteoglycan perlecan maps to the N-terminal domain-I. J Bone Miner Res 17:48-55
24. Friedrich MVK, Göhring W, Mörgelin M, Brancaccio A, David G, Timpl R (1999) Structural basis of GAG modification and of heterotypic interactions of perlecan domain V. J Mol Biol 294:259-270
25. Getzy LL, Malemud CJ, Goldberg VM, Moskowitz RW (1982) Factors influencing metachromatic staining in paraffin-embedded sections of rabbit and human articular cartilage: a comparison of the safranin O and toluidine blue O techniques. J Histotechnol 5:111-116
26. Gibson G, Lin D-L, Francki K, Caterson B, Foster B (1996) Type X collagen is colocalized with a proteoglycan epitope to form distinct morphological structures in bovine growth cartilage. Bone 19:307-315
27. Graham LD, Whitelock JM, Underwood PA (1999) Expression of human perlecan domain-I as a recombinant heparan sulphate proteoglycan with 20 kDa glycosaminoglycan chains. Biochem Biophys Res Commun 256:542-548
28. Grave B (2000) Localisation of TGF-βs and perlecan in mouse skull development. Ann R Aust Coll Dent Surg 15:352-356
29. Gysen P, Franchimont PJ (1984) Radioimmunoassay of proteoglycans. J Immunoassay 5:221-243
30. Handler M, Yurchenko PD, Iozzo RV (1997) Developmental expression of perlecan during murine embryogenesis. Dev Dyn 210:130-145
31. Hopf M, Göhring W, Mann K, Timpl R (2001a) Mapping of binding sites for nidogens, fibulin-2, fibronectin and heparin to different IG modules of perlecan. J Mol Biol 311:529-541
32. Hopf M, Göhring W, Ries A, Timpl R, Hohenester E (2001b) Crystal structure and mutational analysis of a perlecan-binding fragment of nidogen-1. Nat Struct Biol 8:634-640
33. Inkinen RI, Lammi MJ, Lehmonen S, Puustjarvi K, Kääpä E, Tammi MI (1998) Relative increase of biglycan and decorin and altered chondroitin sulfate epitopes in the degenerating human intervertebral disc. J Rheumatol 25:506-514
34. Iozzo RV, San Antonio JD (2001) Heparan sulphate proteoglycans: heavy hitters in the angiogenesis arena. J Clin Invest 108:349-355
35. Klint P, Claesson-Welsh L (1999) Signal transduction by fibroblast growth factor receptors. Front Biosci 4:D165-D177
36. Knox S, Melrose J, Whitelock J (2001) Electrophoretic, biosensor and bioactivity analyses of perlecans of different cellular origins. Proteomics 1:1534-1541
37. Knox S, Merry C, Stringer S, Melrose J, Whitelock J (2002) Not all perlecans are created equal: interactions with fibroblast growth factor-2 (FGF-2) and FGF receptors. J Biol Chem 277:14657-14665
38. Knudson CB, Knudson W (1993) Hyaluronan-binding proteins in development, tissue homeostasis, and disease FASEB J 7:1233-1241
39. Knudson CB, Knudson W (2001) Cartilage proteoglycans. Semin Cell Dev Biol 12:69-78
40. Kunjathoor VV, Chiu DS, O'Brien KD, LeBouef RC (2002) Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis. Ather Thromb Vasc Biol 22:462-468
41. Lammi P, Lammi MJ, Tammi RH, Helminen HJ, Espanha RH (2001) Strong hyaluronan expression in the full thickness rat articular cartilage repair tissue. Histochem Cell Biol 115:301-308
42. Liddington RC (2001) Mapping out the basement membrane. Nat Struct Biol 8:573-574
43. Mayne R, Zettergren JG, Mayne PM, Bedwell NW (1980) Isolation and partial characterization of basement membrane-like collagens from bovine thoracic aorta. Artery 7:262-280
44. McArthur ME, Irving-Rodgers HFI, Byers S, Rodgers RJ (2000) Identification and immunolocalisation of decorin, versican, perlecan, nidogen, and chondroitin sulfate proteoglycans in bovine small-antral ovarian follicles. Biol Reprod 63:913-924
45. Melrose J, Whitelock J, Ghosh P, Xu Q (1998) Pathogenesis of abdominal aortic aneurysms: possible role of differential production of proteoglycans by smooth muscle cells J Vasc Surg 28:676-686
46. Melrose J, Smith S, Ghosh P (2000) Differential expression of proteoglycan epitopes by ovine intervertebral disc cells grown in alginate bead culture. J Anat 197:189-198
47. Melrose J, Ghosh P, Taylor TKF (2001) Comparative analysis of the differential spatial and temporal distributions of the large (aggrecan, versican) and small (decorin, biglycan, fibromodulin) disc proteoglycans. J Anat 198:3-15
48. Melrose J, Tammi M, Smith S (2002) Visualisation of hyaluronan and hyaluronan binding proteins within ovine vertebral cartilages using biotinylated aggrecan G1-link complex and biotinylated hyaluronan oligosaccharides. Histochem Cell Biol 117:327-333
49. Murdoch AD, Dodge GR, Cohen I, Tuan RS, Iozzo RV (1992) Primary structure of the human heparan sulphate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecule, and epidermal growth factor. J Biol Chem 267:8544-8557
50. Murdoch AD, Liu B, Schwarting R, Tuan RS, Iozzo RV (1994) Wide spread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridisation. J Histochem Cytochem 42:239-249
51. Nakahama M, Murakami T, Kusachi S, Naito I, Takeda K, Ohnishi H, Komatsubara I, Oka T, Ninomiya Y, Tsuji T (2000) Expression of perlecan proteoglycan in the infarct zone of mouse myocardial infarction. J Mol Cardiol 32:1087-1100
52. Nicole S, Davoine CS, Topaloglu H, Cattolico L, Barral D, Beighton P, Hamida CB, Hammouda H, Cruaund C, White PS, Samson D, Urtizberea JA, Lehmann-Horn F, Weissenbach J, Hentati F, Fontaine B (2000) Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet 26:480-483
53. Noonan DM, Fulle A, Nalente P, Cai S, Horigan E, Sasaki M, Yamada Y, Hassell JR (1991) The complete sequence of perlecan, a basement membrane heparan sulphate proteoglycan reveals extensive similarity with laminin-A chain, low density lipoprotein receptor and the neural cell adhesion molecule. J Biol Chem 266:22939-22947
54. Nugent MA, Nugent HM, Iozzo RV, Sanchak K, Edelman ER (2000) Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia. Proc Natl Acad Sci USA 97:6722-6727
55. Parkkinen JJ, Häkkinen TP, Savolainen S, Wang C, Tammi R, Agren UM, Lammi MJ, Arokoski J, Helminen HJ, Tammi MI (1996) Distribution of hyaluronan in articular cartilage as probed by a biotinylated binding region of aggrecan. Histochem Cell Biol 105:187-194
56. Pavasant P, Shirazi T, Underhill CB (1996) Hyaluronan contributes to the enlargement of hypertrophic lacunae in the growth plate. J Cell Sci 109:327-334
57. Rayan GM, Haaksma CJ, Tomasek JL (2000) Basement membrane chondroitin sulfate proteoglycan and vascularisation of the developing mammalian limb bud. J Hand Surg 25A:150-158
58. Roberts S, Menage J, Duance V, Wotton S, Ayad S (1991) 1991 Volvo Award in Basic Sciences. Collagen types around the cells of the intervertebral disc and cartilage end plate: an immunolocalization study. Spine 16:1030-1038
59. Sasono Y, Takahashi I, Mizoguchi I, Kagayama M, Takita H, Kuboki Y (1998) Type X collagen is not localised in hypertrophic or calcified cartilage in the developing rat trachea. Anat Embryol 197:399-403
60. Schmid TM, Popp RG, Linsenmeyer TF (1990) Hypertrophic cartilage matrix. Type X collagen, supramolecular assembly and calcification. Ann N Y Acad Sci 580:64-73
61. Schmid TM, Bonen DK, Luchene L, Linsenmeyer TF (1991) Late events in chondrocyte differentiation: hypertrophy, type X collagen synthesis and matrix calcification. In Vivo 5:533-540
62. Smith SE, French MM, Julian J, Paria BC, Dey SK, Carson DD (1997) Expression of heparan sulphate proteoglycan (perlecan) in the mouse blastocyst is regulated during normal and delayed implantation. Dev Biol 184:38-47
63. Sundarraj N, Fite D, Ledbetter S, Chakravarti S, Hassell JR (1995) Perlecan is a component of cartilage matrix and promotes chondrocyte attachment. J Cell Sci 108:2663-2672
64. Sundarraj N, Fite D, Belak R, Sundarraj S, Rada J, Okamoto S, Hassell J (1998) Proteoglycan distribution during healing of corneal stromal wounds in chick. Exp Eye Res 67:433-442
65. Tammi R, Rilla K, Pienimäki J-P, MacCallum DK, Hogg M, Luukkonen M, Hascall VC, Tammi M (2001) Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J Biol Chem 276:35111-35122
66. Tapanadechopone P, Hassell JR, Rigatti B, Couchman JR (1999) Localisation of glycosaminoglycan substitution sites on domain V of mouse perlecan. Biochem Biophys Res Commun 265:680-690
67. Toole BP (1990) Hyaluronan and its binding proteins the hyaladherins. Curr Opin Cell Biol 2:839-844
68. Toole BP (1997) Hyaluronan in morphogenesis. J Intern Med 242:35-40
69. Visco DM, Johnstone B, Hill MA, Jolly GA, Caterson B (1993) Immunohistochemical analysis of 3-B-3(-) and 7-D-4 epitope expression in canine osteoarthritis. Arthritis Rheum 36:1718-1725
70. Wang L, Verbruggen G, Almqvist KF, Elewaut D, Broddelez C, Veys EM (2001) Flow cytometric analysis of the human articular chondrocyte phenotype. Osteoarthritis Cartilage 9:73-84
71. Whitelock JM (2001) Purification of perlecan from endothelial cells. In: Iozzo RV (ed) Methods in molecular biology, vol 171. Proteoglycan protocols. Humana Press, Totowa, pp 27-34
72. Whitelock JM, Graham LD, Melrose J, Murdoch AD, Iozzo RV, Underwood A (1999) Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells. Matrix Biol 18:163-178